USA flag logo/image

An Official Website of the United States Government

INTRAPARTUM FETAL PH MONITORING IN THE PREMATURE FETUS.

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
7954
Program Year/Program:
1988 / SBIR
Agency Tracking Number:
7954
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
International Biomedics Inc
1631 220th Ave Se Bothell, WA 98021
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1988
Title: INTRAPARTUM FETAL PH MONITORING IN THE PREMATURE FETUS.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

FETAL BLOOD PH IS VALUABLE FOR HIGH-RISK CARE. CLINICAL EVALUATION OF OUR PATENTED CONTINUOUS INTRAPARTUM FETAL SCALP TISSUE PH/ECG PROBE (OBPH PROBE) DEMONSTRATED PH CAN BE MONITORED BY OUR PROBE IN THE TERM FETUS. OUR AIM ISTO OFFER OBPH PROBES DESIGNED FOR THE PRETERM FETUS AND FOR THE FETUS WITH A VERY HAIRY SCALP. (HAIR HINDERS SEATING OF THE PROBE). THE DIMENSIONS OF THE CURRENT OBPH PROBE'S SPIRAL RELATE TO THE PI'S STUDY OF INTRAPARTUM PELVIMETRY X-RAYS IN TERM PREGNANCIES. (HOCHBERG, 1981) NO OTHER RELEVANT LITERATURE WAS FOUND. ACCORDINGLY, DURING PHASE I WE WILL GATHER, TABULATE AND ANALYZE THE FETAL ANATOMIC AND CLINICAL DATA NEEDED TO DESIGN SAFE NEW OBPH PROBES. AND, WE WILL DEVELOPCLINICAL CRITERIA FOR PROBE SELECTION. INVESTIGATORS WILL USE INTRAVAGINAL ULTRASOUND IMAGING FOR FETAL SCALP THICKNESS (FST) MEASURES AND THEY WILL PROVIDE RELEVANT CLINICAL DATA. PROBES WILL BE DESIGNED AND BENCH TESTED. PHASE II WILL INCLUDE FDA/IDE CONTROLLED CLINICAL TRIALS.

Principal Investigator:


0

Business Contact:

Small Business Information at Submission:

International Biomedics Inc
1631 220th Ave Se Bothell, WA 98021

EIN/Tax ID:
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No